Skip to Main Content

Author Details

Paz Polak
McGill University
2006
58
31
PMIDPaper TitleJournal TitlePublished Year
35039446Long-term tumour dormancy in a <i>BRCA1</i> heterozygote.J Med Genet2023
37290439Elevated cfDNA after exercise is derived primarily from mature polymorphonuclear neutrophils, with a minor contribution of cardiomyocytes.Cell Rep Med2023
36697405Author Correction: A framework for clinical cancer subtyping from nucleosome profiling of cell-free DNA.Nat Commun2023
35039446Long-term tumour dormancy in a <i>BRCA1</i> heterozygote.J Med Genet2023
37290439Elevated cfDNA after exercise is derived primarily from mature polymorphonuclear neutrophils, with a minor contribution of cardiomyocytes.Cell Rep Med2023
36697405Author Correction: A framework for clinical cancer subtyping from nucleosome profiling of cell-free DNA.Nat Commun2023
35058359Cell-free DNA profiling informs all major complications of hematopoietic cell transplantation.Proc Natl Acad Sci U S A2022
35948631Diverse mutational landscapes in human lymphocytes.Nature2022
36119527Characterization of genetic predisposition to molecular subtypes of breast cancer in Brazilian patients.Front Oncol2022
35783256The Great Majority of Homologous Recombination Repair-Deficient Tumors Are Accounted for by Established Causes.Front Genet2022
35402908Machine-learning of complex evolutionary signals improves classification of SNVs.NAR Genom Bioinform2022
36481665Author Correction: A deep learning system accurately classifies primary and metastatic cancers using passenger mutation patterns.Nat Commun2022
36463275A framework for clinical cancer subtyping from nucleosome profiling of cell-free DNA.Nat Commun2022
36922933Whole-exome Sequencing of Nigerian Prostate Tumors from the Prostate Cancer Transatlantic Consortium (CaPTC) Reveals DNA Repair Genes Associated with African Ancestry.Cancer Res Commun2022
36676020COOBoostR: An Extreme Gradient Boosting-Based Tool for Robust Tissue or Cell-of-Origin Prediction of Tumors.Life (Basel)2022
35058359Cell-free DNA profiling informs all major complications of hematopoietic cell transplantation.Proc Natl Acad Sci U S A2022
35402908Machine-learning of complex evolutionary signals improves classification of SNVs.NAR Genom Bioinform2022
35783256The Great Majority of Homologous Recombination Repair-Deficient Tumors Are Accounted for by Established Causes.Front Genet2022
36922933Whole-exome Sequencing of Nigerian Prostate Tumors from the Prostate Cancer Transatlantic Consortium (CaPTC) Reveals DNA Repair Genes Associated with African Ancestry.Cancer Res Commun2022
36463275A framework for clinical cancer subtyping from nucleosome profiling of cell-free DNA.Nat Commun2022
36676020COOBoostR: An Extreme Gradient Boosting-Based Tool for Robust Tissue or Cell-of-Origin Prediction of Tumors.Life (Basel)2022
36481665Author Correction: A deep learning system accurately classifies primary and metastatic cancers using passenger mutation patterns.Nat Commun2022
36119527Characterization of genetic predisposition to molecular subtypes of breast cancer in Brazilian patients.Front Oncol2022
35948631Diverse mutational landscapes in human lymphocytes.Nature2022
34090884Hybrid Stomach-Intestinal Chromatin States Underlie Human Barrett's Metaplasia.Gastroenterology2021
34240211Li-Fraumeni Syndrome in the Cancer Genomics Era.J Natl Cancer Inst2021
34090884Hybrid Stomach-Intestinal Chromatin States Underlie Human Barrett's Metaplasia.Gastroenterology2021
33714591Gemcitabine plus nab-paclitaxel versus FOLFIRINOX for unresected pancreatic cancer: Comparative effectiveness and evaluation of tumor growth in Veterans.Semin Oncol2021
34792595Companion Tumor Sequencing to Assess the Clinical Significance of Germline Sequencing in Children With Cancer.JAMA Netw Open2021
34433815Current gene panels account for nearly all homologous recombination repair-associated multiple-case breast cancer families.NPJ Breast Cancer2021
33714591Gemcitabine plus nab-paclitaxel versus FOLFIRINOX for unresected pancreatic cancer: Comparative effectiveness and evaluation of tumor growth in Veterans.Semin Oncol2021
34792595Companion Tumor Sequencing to Assess the Clinical Significance of Germline Sequencing in Children With Cancer.JAMA Netw Open2021
34433815Current gene panels account for nearly all homologous recombination repair-associated multiple-case breast cancer families.NPJ Breast Cancer2021
34240211Li-Fraumeni Syndrome in the Cancer Genomics Era.J Natl Cancer Inst2021
32668120Bilateral Tumors - Inherited or Acquired?N Engl J Med2020
32083210Somatic mutation landscape reveals differential variability of cell-of-origin for primary liver cancer.Heliyon2020
32024849A deep learning system accurately classifies primary and metastatic cancers using passenger mutation patterns.Nat Commun2020
32651179Genomic Profiling of Prostate Cancers from Men with African and European Ancestry.Clin Cancer Res2020
32594164Coronavirus 2019 and People Living With Human Immunodeficiency Virus: Outcomes for Hospitalized Patients in New York City.Clin Infect Dis2020
32816949A Preclinical Trial and Molecularly Annotated Patient Cohort Identify Predictive Biomarkers in Homologous Recombination-deficient Pancreatic Cancer.Clin Cancer Res2020
32846073Olaparib for Metastatic Castration-Resistant Prostate Cancer. Reply.N Engl J Med2020
32846071Olaparib for Metastatic Castration-Resistant Prostate Cancer.N Engl J Med2020
32668122Etiologic Index - A Case-Only Measure of <i>BRCA1/2</i>-Associated Cancer Risk.N Engl J Med2020
32668120Bilateral Tumors - Inherited or Acquired?N Engl J Med2020
32083210Somatic mutation landscape reveals differential variability of cell-of-origin for primary liver cancer.Heliyon2020
32024849A deep learning system accurately classifies primary and metastatic cancers using passenger mutation patterns.Nat Commun2020
32651179Genomic Profiling of Prostate Cancers from Men with African and European Ancestry.Clin Cancer Res2020
32594164Coronavirus 2019 and People Living With Human Immunodeficiency Virus: Outcomes for Hospitalized Patients in New York City.Clin Infect Dis2020
32846073Olaparib for Metastatic Castration-Resistant Prostate Cancer. Reply.N Engl J Med2020
32846071Olaparib for Metastatic Castration-Resistant Prostate Cancer.N Engl J Med2020
  • 1 - 50 of 116

Recommended Authors

Shantao Li
Yale University
Career Start Year 2015
Number of shared co-authors 1
Richard de Borja
The Hospital for Sick Children
Career Start Year 2012
Number of shared co-authors 12
Ludmil B Alexandrov
Moores Cancer Center, university of california san diego
Career Start Year 2007
Number of shared co-authors 20
Sigve Nakken
University of Oslo
Career Start Year 2007
Number of shared co-authors 7
Moritz Gerstung
German Cancer Research Centre DKFZ
Career Start Year 2007
Number of shared co-authors 8
Barbara Hutter
National Center for Tumor Diseases (NCT) Heidelberg
Career Start Year 2006
Number of shared co-authors 12
Nicola Waddell
QIMR Berghofer Medical Research Institute
Career Start Year 2006
Number of shared co-authors 17
David C Wedge
Manchester Cancer Research Centre, University of Manchester
Career Start Year 2006
Number of shared co-authors 12
Ann-Marie Patch
QIMR Berghofer Medical Research Institute
Career Start Year 2005
Number of shared co-authors 14
Abel Gonzalez-Perez
Universitat Pompeu Fabra
Career Start Year 2005
Number of shared co-authors 19
David Jones
Wellcome Sanger Institute
Career Start Year 2005
Number of shared co-authors 10
Jamie K Teer
H. Lee Moffitt Cancer Center and Research Institute
Career Start Year 2005
Number of shared co-authors 2
Joachim Weischenfeldt
University of Copenhagen
Career Start Year 2004
Number of shared co-authors 19
Chris Greenman
University of East Anglia
Career Start Year 2004
Number of shared co-authors 4
Keiran Raine
Wellcome Sanger Institute
Career Start Year 2004
Number of shared co-authors 12
Matthias Schlesner
University of Augsburg
Career Start Year 2004
Number of shared co-authors 13
Jianmin Wang
Roswell Park Comprehensive Cancer Center
Career Start Year 2003
Number of shared co-authors 2
Peter Van Loo
The Francis Crick Institute
Career Start Year 2003
Number of shared co-authors 12
Olivier Harismendy
University of California
Career Start Year 2003
Number of shared co-authors 1
Andrew Menzies
Wellcome Sanger Institute
Career Start Year 2002
Number of shared co-authors 9
Jon Teague
Wellcome Sanger Institute
Career Start Year 2002
Number of shared co-authors 10
Nuria Lopez-Bigas
Universitat Pompeu Fabra
Career Start Year 1999
Number of shared co-authors 39
Colin C Pritchard
University of Washington, USA Brotman Baty Institute for Precision Medicine
Career Start Year 1999
Number of shared co-authors 17
Serena Nik-Zainal
Early Cancer Institute, University of Cambridge
Career Start Year 1999
Number of shared co-authors 12
Li Ding
McDonnell Genome Institute, Washington University School of Medicine
Career Start Year 1997
Number of shared co-authors 28
John V Pearson
QIMR Berghofer Medical Research Institute
Career Start Year 1996
Number of shared co-authors 17
Adam Butler
Wellcome Sanger Institute
Career Start Year 1996
Number of shared co-authors 10
Curtis Gumbs
The University of Texas MD Anderson Cancer Center
Career Start Year 1995
Number of shared co-authors 4
Phillip A Futreal
The University of Texas MD Anderson Cancer Center
Career Start Year 1991
Number of shared co-authors 18
Michael R Stratton
Wellcome Sanger Institute
Career Start Year 1987
Number of shared co-authors 27

Collaborators

Gad Getz
Broad Institute of the Massachusetts Institute of Technology and Harvard
Co-authored papers 18
William D Foulkes
Segal Cancer Centre, Jewish General Hospital
Co-authored papers 15
Rosa Karlic
University of Zagreb
Co-authored papers 11
Shamil R Sunyaev
Harvard Medical School
Co-authored papers 10
Jaegil Kim
Co-authored papers 10
Michael S Lawrence
Co-authored papers 9
Amnon Koren
Co-authored papers 7
Nicholas J Haradhvala
Co-authored papers 7
Ignaty Leshchiner
Broad Institute of Massachusetts Institute of Technology and Harvard
Co-authored papers 6
Atanas Kamburov
Broad Institute of Harvard and MIT
Co-authored papers 6
Julian M Hess
Broad Institute of MIT and Harvard
Co-authored papers 5
Kirsten Kübler
Co-authored papers 5
Dimitri Livitz
Co-authored papers 5
Daniel Rosebrock
Co-authored papers 5
Matthew Meyerson
Broad Institute
Co-authored papers 4
Eric S Lander
Vanderbilt-Ingram Cancer Center, Vanderbilt University
Co-authored papers 4
Eliezer M Van Allen
Dana-Farber Cancer Institute
Co-authored papers 4
Todd R Golub
Broad Institute of MIT and Harvard
Co-authored papers 4
Stacey Gabriel
Broad Institute of MIT and Harvard
Co-authored papers 4
Chip Stewart
Broad Institute of MIT and Harvard
Co-authored papers 4
John A Stamatoyannopoulos
Altius Institute for Biomedical Sciences
Co-authored papers 4
Petar Stojanov
Co-authored papers 3
Peter S Nelson
Fred Hutchinson Cancer Center
Co-authored papers 3
Steven A McCarroll
Co-authored papers 3
Hidewaki Nakagawa
RIKEN Center for Integrative Medical Sciences
Co-authored papers 3
Alan D D'Andrea
Dana-Farber Cancer Institute
Co-authored papers 3
Robert E Thurman
University of Washington
Co-authored papers 3
Adam Kiezun
Co-authored papers 3
Levi A Garraway
Broad Institute of Harvard and MIT
Co-authored papers 3
Girish N Nadkarni
Icahn School of Medicine at Mount Sinai
Co-authored papers 2
Release 1.2